← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 15, 2019Last known activity
Oct 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (11)
- NCT06051630Sponsor investigatorN/AOct 1, 2023
- NCT06051630Lead sponsorN/AOct 1, 2023
- NCT06051630Reponsible party - principal investigatorN/AOct 1, 2023
- NCT05768191Sponsor investigatorPhase 4Jun 15, 2023
- NCT05768191Lead sponsorPhase 4Jun 15, 2023
- NCT05768191Reponsible party - principal investigatorPhase 4Jun 15, 2023
- NCT05588752Lead sponsorN/AOct 20, 2022
- NCT05588752Reponsible party - principal investigatorN/AOct 20, 2022
- NCT05031676Reponsible party - principal investigatorN/AFeb 15, 2019
- NCT05031676Lead sponsorN/AFeb 15, 2019
- NCT05031676Study directorN/AFeb 15, 2019
Details
- Last known activity
- Oct 1, 2023